Statistics

Total Visits

Views
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)58

Select a period of time:

Number of views in the range

Views
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)33

Views

Views
October 20245
November 20243
December 20242
January 20253
February 202510
March 202510
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States13
United Kingdom4
Canada1
 

Top cities views

Views
Huntington Beach1
Toronto1